Rovelizumab Biosimilar – Anti-ITGAL, CD11a, ITGB2, CD18 mAb – Research Grade

Reference:
Product nameRovelizumab Biosimilar - Anti-ITGAL, CD11a, ITGB2, CD18 mAb - Research Grade
SourceCAS 339086-79-2
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsRovelizumab,Hu23F2G,ITGAL, CD11a, ITGB2, CD18,anti-ITGAL, CD11a, ITGB2, CD18
ReferencePX-TA1216
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-nd
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Rovelizumab Biosimilar – Anti-ITGAL, CD11a, ITGB2, CD18 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGAL recombinant protein
Antigen

ITGAL recombinant protein

PX-P5176 414$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 189$
Stable Isotope Labelled Rovelizumab Biosimilar – Anti-ITGAL/CD11a/ITGB2/CD18 mAb – Research Grade
SIL

Stable Isotope Labelled Rovelizumab Biosimilar – Anti-ITGAL/CD11a/ITGB2/CD18 mAb – Research Grade

PX-TA1216-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products